REQUEST A DEMO
Total
USD $0.00
Search more companies

Haisco Pharmaceutical Group Co., Ltd. (China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Haisco Pharmaceutical Group Co., Ltd. Profile Updated: March 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Haisco Pharmaceutical Group Co., Ltd. is a modern pharmaceutical group located in Shannan. The company specializes in the research, development, production, and sales of pharmaceutical preparations and raw materials. Their main products include hepatobiliary drugs such as polyene phosphatidylcholine injection, sodium fusidate injection for special anti-infection use, parenteral nutrition drug transformation sugar injection series, and injection lipid-soluble vitamin series.

Headquarters
17 W. Side Sanxiang Boulevard Zetang Town Shannan Prefecture Tibet
Shannan; Tibet; Postal Code: 856000

Contact Details: Purchase the Haisco Pharmaceutical Group Co., Ltd. report to view the information.

Website: http://www.haisco.com

Basic Information
Total Employees:
Purchase the Haisco Pharmaceutical Group Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Haisco Pharmaceutical Group Co., Ltd. report to view the information.
Registered Capital:
Purchase the Haisco Pharmaceutical Group Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Haisco Pharmaceutical Group Co., Ltd. report to view the information.
Incorporation Date:
August 26, 2005
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
35.86%
Purchase this report to view the information.
20.06%
Purchase this report to view the information.
13.83%
Purchase this report to view the information.
5.24%
Purchase this report to view the information.
3.81%
Subsidiaries
Chengdu Haisco Biotechnology Co., Ltd.
100%
Chengdu Haisco Pharmaceutical Co., Ltd.
100%
HAISCO PHA RMACEUTICAL(AUSTRALIA)PTY LTD
100%
Company Performance
Financial values in the chart are available after Haisco Pharmaceutical Group Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
13.7%
Total operating revenue
12.71%
Operating profit (EBIT)
138.09%
EBITDA
123.06%
Net Profit (Loss) for the Period
96.29%
Total assets
11.9%
Total equity
41.09%
Operating Profit Margin (ROS)
4.38%
Net Profit Margin
3.55%
Return on Equity (ROE)
1.39%
Debt to Equity Ratio
-37.6%
Quick Ratio
0.42%
Cash Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?